LeMaitre Vascular

Yahoo Finance • 2 months ago

Penumbra, Corcept, Elanco, ResMed, and LeMaitre Stocks Trade Up, What You Need To Know

What Happened? A number of stocks jumped in the afternoon session after comments from a key Federal Reserve official bolstered hopes for an interest rate cut. New York Federal Reserve President John Williams stated he sees “room for a fu... Full story

Yahoo Finance • 2 months ago

LeMaitre to Participate in Upcoming Investor Conferences

BURLINGTON, Mass., Nov. 12, 2025 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that management will participate in three upcoming investor conferences. Jefferies London Healthcare Conference 2025 Tuesday, No... Full story

Yahoo Finance • 2 months ago

LeMaitre targets 40% Q4 operating income growth and 29% margin as Artegraft expansion accelerates

Earnings Call Insights: LeMaitre Vascular, Inc. (LMAT) Q3 2025 MANAGEMENT VIEW * CEO George LeMaitre highlighted "organic sales growth of 12% and a better-than-expected gross margin" for Q3, noting "several bottom line records, op inco... Full story

Yahoo Finance • 2 months ago

LeMaitre Vascular declares $0.20 dividend

* LeMaitre Vascular (LMAT [https://seekingalpha.com/symbol/LMAT]) declares $0.20/share quarterly dividend [https://seekingalpha.com/pr/20297939-lemaitre-q3-2025-financial-results], in line with previous. * Forward yield [https://seekin... Full story

Yahoo Finance • 3 months ago

LeMaitre Will Announce Third Quarter 2025 Earnings Results on November 6, 2025

BURLINGTON, Mass., Oct. 09, 2025 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its third quarter 2025 financial results on Thursday, November 6, 2025, after the market close. The company h... Full story

Yahoo Finance • 3 months ago

AbbVie, AMN Healthcare Services, LeMaitre, Waters Corporation, and Organon Shares Skyrocket, What You Need To Know

What Happened? A number of stocks jumped in the afternoon session after reports revealed a potential drug-pricing agreement between the White House and the pharmaceutical industry. The Trump administration is advancing its “Most Favored... Full story

Yahoo Finance • 4 months ago

LeMaitre Vascular Inc. (NASDAQ:LMAT) Exemplifies Quality Investing Principles in Caviar Cruise Screen

Quality investing focuses on identifying companies with durable competitive advantages, strong financial health, and consistent profitability, with the goal of holding these investments for the long term. The Caviar Cruise stock screen, in... Full story

Yahoo Finance • 4 months ago

LeMaitre Vascular, Inc. (LMAT) Gains Edge in Niche Vascular Device Market

In this article, we will be taking a look at the 7 Hot Healthcare Stocks to Buy Right Now. LeMaitre Vascular, Inc. stands fifth among them. LeMaitre Vascular, Inc. (NASDAQ:LMAT) is a medical device company specializing in products for per... Full story

Yahoo Finance • 5 months ago

LeMaitre to Participate at Upcoming Investor Conferences in September

BURLINGTON, Mass., Aug. 28, 2025 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that management will participate in four upcoming investor conferences. 2025 Wells Fargo Healthcare Conference Wednesday, Septem... Full story

Yahoo Finance • 5 months ago

Ex-Dividend Reminder: CenterPoint Energy, LeMaitre Vascular and Concentra Group Holdings Parent

Looking at the universe of stocks we cover at Dividend Channel, on 8/21/25, CenterPoint Energy, Inc (Symbol: CNP), LeMaitre Vascular Inc (Symbol: LMAT), and Concentra Group Holdings Parent Inc (Symbol: CON) will all trade ex-dividend for t... Full story

Yahoo Finance • 5 months ago

LeMaitre raises 2025 revenue guidance to $251M with 15% organic growth as international launches accelerate

Earnings Call Insights: LeMaitre Vascular (LMAT) Q2 2025 MANAGEMENT VIEW * George LeMaitre, CEO, stated that "Q2 was strong across the board, with sales up 15%, a 70% gross margin and EPS up 16%. As a result, we're increasing full year... Full story

Yahoo Finance • 5 months ago

LeMaitre Q2 2025 Financial Results

BURLINGTON, Mass., Aug. 05, 2025 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq: LMAT), a provider of vascular devices, implants, and services, today reported Q2 2025 results, announced a quarterly dividend of $0.20/share, and provi... Full story

Yahoo Finance • 6 months ago

JMP reiterates Market Outperform rating on LeMaitre Vascular stock ahead of earnings

Investing.com - JMP Securities has reiterated its Market Outperform rating and $113.00 price target on LeMaitre Vascular (NASDAQ:LMAT) ahead of the company’s second-quarter 2025 earnings release scheduled for August 5. The target represent... Full story

Yahoo Finance • 6 months ago

Tandem Diabetes, Solventum, LeMaitre, UFP Technologies, and Artivion Stocks Trade Down, What You Need To Know

What Happened? A number of stocks fell in the afternoon session after the U.S. administration announced a sharp escalation in trade tensions by threatening new tariffs on Canada. The wider market sentiment turned negative after the White... Full story

Yahoo Finance • 6 months ago

LeMaitre Will Announce Second Quarter 2025 Earnings Results August 5, 2025

BURLINGTON, Mass., July 08, 2025 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its second quarter 2025 financial results on Tuesday, August 5, 2025, after the market close. The company has... Full story

Yahoo Finance • 6 months ago

LeMaitre Vascular's SWOT analysis: niche market leader faces growth challenges

LeMaitre Vascular Inc . (NASDAQ:LMAT), a medical device company specializing in vascular devices, has been navigating a complex landscape of growth opportunities and operational challenges. The company’s strong position in niche markets an... Full story

Yahoo Finance • 7 months ago

Anteris Appoints David Roberts and Gregory Moss to its Board of Directors

MINNEAPOLIS and BRISBANE, Australia, June 09, 2025 (GLOBE NEWSWIRE) -- Anteris Technologies Global Corp. (Anteris or the Company) (NASDAQ: AVR, ASX: AVR) a global structural heart company committed to designing, developing, and commercia... Full story

Yahoo Finance • 8 months ago

LeMaitre to Present at the Bank of America Securities 2025 Healthcare Conference

BURLINGTON, Mass., May 05, 2025 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that David Roberts, President, will present at the Bank of America Securities 2025 Healthcare Conference on Tuesday, May 13, 2024,... Full story

Yahoo Finance • 9 months ago

LeMaitre Will Announce First Quarter 2025 Earnings Results May 1, 2025

BURLINGTON, Mass., April 07, 2025 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its first quarter 2025 financial results on Thursday, May 1, 2025, after the market close. The company has s... Full story

Yahoo Finance • 9 months ago

LeMaitre to Present at the 24th Annual Needham Virtual Healthcare Conference

BURLINGTON, Mass., April 01, 2025 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that management will present at the 24th Annual Needham Virtual Healthcare Conference on Tuesday, April 8, 2025, at 3:45 PM EDT.... Full story